1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer Stem Cell Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Cell Culturing
  • 1.4.3 Cell Separation
  • 1.4.4 Cell Analysis
  • 1.4.5 Molecular Analysis
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Cancer Stem Cell Market Share by Application: 2020 VS 2026
  • 1.5.2 Stem Cell Based Cancer Therapy
  • 1.5.3 Targeted CSCs
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Stem Cell Market Perspective (2015-2026)
• 2.2 Global Cancer Stem Cell Growth Trends by Regions
  • 2.2.1 Cancer Stem Cell Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Stem Cell Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Stem Cell Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer Stem Cell Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer Stem Cell Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Stem Cell Players by Market Size
  • 3.1.1 Global Top Cancer Stem Cell Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer Stem Cell Market Concentration Ratio
  • 3.2.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2019
• 3.3 Cancer Stem Cell Key Players Head office and Area Served
• 3.4 Key Players Cancer Stem Cell Product Solution and Service
• 3.5 Date of Enter into Cancer Stem Cell Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer Stem Cell Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer Stem Cell Market Size by Application (2015-2020)
• 5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Stem Cell Market Size (2015-2020)
• 6.2 Cancer Stem Cell Key Players in North America (2019-2020)
• 6.3 North America Cancer Stem Cell Market Size by Type (2015-2020)
• 6.4 North America Cancer Stem Cell Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer Stem Cell Market Size (2015-2020)
• 7.2 Cancer Stem Cell Key Players in Europe (2019-2020)
• 7.3 Europe Cancer Stem Cell Market Size by Type (2015-2020)
• 7.4 Europe Cancer Stem Cell Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer Stem Cell Market Size (2015-2020)
• 8.2 Cancer Stem Cell Key Players in China (2019-2020)
• 8.3 China Cancer Stem Cell Market Size by Type (2015-2020)
• 8.4 China Cancer Stem Cell Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer Stem Cell Market Size (2015-2020)
• 9.2 Cancer Stem Cell Key Players in Japan (2019-2020)
• 9.3 Japan Cancer Stem Cell Market Size by Type (2015-2020)
• 9.4 Japan Cancer Stem Cell Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer Stem Cell Market Size (2015-2020)
• 10.2 Cancer Stem Cell Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer Stem Cell Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer Stem Cell Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer Stem Cell Market Size (2015-2020)
• 11.2 Cancer Stem Cell Key Players in India (2019-2020)
• 11.3 India Cancer Stem Cell Market Size by Type (2015-2020)
• 11.4 India Cancer Stem Cell Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer Stem Cell Market Size (2015-2020)
• 12.2 Cancer Stem Cell Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer Stem Cell Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer Stem Cell Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific, Inc.
  • 13.1.1 Thermo Fisher Scientific, Inc. Company Details
  • 13.1.2 Thermo Fisher Scientific, Inc. Business Overview
  • 13.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
  • 13.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific, Inc. Recent Development
• 13.2 AbbVie, Inc.
  • 13.2.1 AbbVie, Inc. Company Details
  • 13.2.2 AbbVie, Inc. Business Overview
  • 13.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
  • 13.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.2.5 AbbVie, Inc. Recent Development
• 13.3 Merck KGaA
  • 13.3.1 Merck KGaA Company Details
  • 13.3.2 Merck KGaA Business Overview
  • 13.3.3 Merck KGaA Cancer Stem Cell Introduction
  • 13.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.3.5 Merck KGaA Recent Development
• 13.4 Bionomics
  • 13.4.1 Bionomics Company Details
  • 13.4.2 Bionomics Business Overview
  • 13.4.3 Bionomics Cancer Stem Cell Introduction
  • 13.4.4 Bionomics Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.4.5 Bionomics Recent Development
• 13.5 Lonza
  • 13.5.1 Lonza Company Details
  • 13.5.2 Lonza Business Overview
  • 13.5.3 Lonza Cancer Stem Cell Introduction
  • 13.5.4 Lonza Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.5.5 Lonza Recent Development
• 13.6 Stemline Therapeutics, Inc.
  • 13.6.1 Stemline Therapeutics, Inc. Company Details
  • 13.6.2 Stemline Therapeutics, Inc. Business Overview
  • 13.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
  • 13.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.6.5 Stemline Therapeutics, Inc. Recent Development
• 13.7 Miltenyi Biotec
  • 13.7.1 Miltenyi Biotec Company Details
  • 13.7.2 Miltenyi Biotec Business Overview
  • 13.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
  • 13.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.7.5 Miltenyi Biotec Recent Development
• 13.8 PromoCell GmbH
  • 13.8.1 PromoCell GmbH Company Details
  • 13.8.2 PromoCell GmbH Business Overview
  • 13.8.3 PromoCell GmbH Cancer Stem Cell Introduction
  • 13.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.8.5 PromoCell GmbH Recent Development
• 13.9 MacroGenics, Inc.
  • 13.9.1 MacroGenics, Inc. Company Details
  • 13.9.2 MacroGenics, Inc. Business Overview
  • 13.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
  • 13.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.9.5 MacroGenics, Inc. Recent Development
• 13.10 OncoMed Pharmaceuticals, Inc.
  • 13.10.1 OncoMed Pharmaceuticals, Inc. Company Details
  • 13.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
  • 13.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
  • 13.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 13.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
• 13.11 Irvine Scientific
  • 10.11.1 Irvine Scientific Company Details
  • 10.11.2 Irvine Scientific Business Overview
  • 10.11.3 Irvine Scientific Cancer Stem Cell Introduction
  • 10.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2015-2020)
  • 10.11.5 Irvine Scientific Recent Development
• 13.12 STEMCELL Technologies Inc.
  • 10.12.1 STEMCELL Technologies Inc. Company Details
  • 10.12.2 STEMCELL Technologies Inc. Business Overview
  • 10.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
  • 10.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 10.12.5 STEMCELL Technologies Inc. Recent Development
• 13.13 Sino Biological Inc.
  • 10.13.1 Sino Biological Inc. Company Details
  • 10.13.2 Sino Biological Inc. Business Overview
  • 10.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
  • 10.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 10.13.5 Sino Biological Inc. Recent Development
• 13.14 BIOTIME, Inc.
  • 10.14.1 BIOTIME, Inc. Company Details
  • 10.14.2 BIOTIME, Inc. Business Overview
  • 10.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
  • 10.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
  • 10.14.5 BIOTIME, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Cancer Stem Cell market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.

Market segment by Type, the product can be split into
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Market segment by Application, split into
Stem Cell Based Cancer Therapy
Targeted CSCs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America